Probiotics in the Development and Treatment of Allergic Disease

Gastroenterology Clinics of North America

Volumn 41, Issue 4, 2012, Pages 747-762

  Isolauri, Erika ^a   Rautava, Samuli ^a   Salminen, Seppo ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Allergy; Breastfeeding; Immunology; Infant; Nutrition; Pregnancy; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ALLERGIC DISEASE; ATOPY; BACTERIAL COLONIZATION; BIFIDOBACTERIUM; BREAST FEEDING; CHILDHOOD DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); DELIVERY; DIET SUPPLEMENTATION; ECZEMA; ENVIRONMENTAL EXPOSURE; HUMAN; HYGIENE; IMMUNE RESPONSE; INFANCY; INFLAMMATION; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; NUTRITION; PERINATAL PERIOD; PRENATAL PERIOD; REVIEW; RISK FACTOR;

BACTERIA; DIET; GASTROINTESTINAL TRACT; HUMANS; HYPERSENSITIVITY; METAGENOME; PROBIOTICS;

EID: 84867970081     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2012.08.007     Document Type: Review

References (68)

1. Rautava S., Ruuskanen O., Ouwehand A., et al. The hygiene hypothesis of atopic disease: an extended version. J Pediatr Gastroenterol Nutr 2004, 38:378-388.
2. Turnbaugh P.J., Ridaura V.K., Faith J.J., et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009, 1:6ra14.
3. Gerrard J.W., Geddes C.A., Reggin P.L., et al. Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 1976, 37:91-100.
4. Strachan D.P. Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260.
5. Hersoug L.G., Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance?. Allergy 2007, 62:1205-1213.
6. Mai X.M., Becker A.B., Sellers E.A., et al. The relationship of breast-feeding, overweight and asthma in preadolescents. J Allergy Clin Immunol 2007, 120:551-556.
7. Kero J., Gissler M., Hemminki E., et al. Could the TH1 and TH2 diseases coexist? evaluation of asthma incidence in children with coeliac disease, type 1 diabetes or rheumatoid arthritis. A register study. J Allergy Clin Immunol 2001, 108:781-783.
8. Kalliomäki M., Kirjavainen P., Eerola E., et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001, 107:129-134.
9. Björkstén B., Sepp E., Julge K., et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001, 108:516-520.
10. He F., Morita H., Hashimoto H., et al. Intestinal Bifidobacterium species induce varying cytokine production. J Allergy Clin Immunol 2002, 109:1035-1036.
11. Harris J.K., Wagner B.D. Bacterial identification and analytic challenges in clinical microbiome studies. J Allergy Clin Immunol 2012, 129:441-442.
12. Renz H., von Mutius E., Brandtzaeg P., et al. Gene-environment interactions in chronic inflammatory disease. Nat Immunol 2011, 12:273-277.
13. Clarke T.B., Davis K.M., Lysenko E.S., et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Med 2010, 16:228-231.
14. Maslowski K.M., Vieira A.T., Mg A., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
15. Cummings J.H., Antoine J.M., Aspiroz F., et al. PASSCLAIM (Process for the Assessment of Scientific Support for Claims on Foods): Gut health and immunity. Eur J Nutr 2004, 43(Suppl 2):118-173.
16. Gallagher A.M., Meijer G.W., Richardson D.P., et al. International Life Sciences Institute Europe Functional Foods Task Force. A standardised approach towards PROving the efficacy of foods and food constituents for health CLAIMs (PROCLAIM): providing guidance. Br J Nutr 2011, 106(Suppl 2):S16-S28.
17. Welch R.W., Antoine J.M., Berta J.L., et al. International Life Sciences Institute Europe Functional Foods Task Force. Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr 2011, 106(Suppl 2):S3-S15.
18. Isolauri E., Kirjavainen P.V., Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation?. Gut 2002, 50(Suppl III):54-59.
19. Favier C.F., de Vos W.M., Akkermans A.D. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe 2003, 9:219-229.
20. Favier C.F., Vaughan E.E., De Vos W.M., et al. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002, 68:219-226.
21. Palmer C., Bik E.M., DiGiulio D.B., et al. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177. 10.1371/journal.pbio.0050177.
22. Koenig J.E., Spor A., Scalfone N., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4578-4585.
23. Mändar R., Livukene K., Ehrenberg A., et al. Amniotic fluid microflora in asymptomatic women at mid-gestation. Scand J Infect Dis 2001, 33:60-62.
24. DiGiulio D. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med 2012, 17:2-11.
25. Onderdonk A.B., Delaney M.L., DuBois A.M., et al. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol 2008, 198:1-7.
26. Mshvildadze M., Neu J. The infant intestinal microbiome: friend or foe?. Early Hum Dev 2010, 86(Suppl 1):67-71.
27. Gueimonde M., Laitinen K., Salminen S., et al. Breast milk: a source of bifidobacteria for infant gut development and maturation?. Neonatology 2007, 92:64-66.
28. Perez P.F., Doré J., Leclerc M., et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells?. Pediatrics 2007, 119:e724-e732.
29. Cabrera-Rubio R., Collado M.C., Laitinen K., et al. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 2012, 96:544-551.
30. Grönlund M.M., Gueimonde M., Laitinen K., et al. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007, 37:1764-1772.
31. Grönlund M.M., Grzeskowiak L., Isolauri E., et al. Influence of mother's intestinal microbiota on gut colonisation in the infant. Gut Microbes 2011, 2:227-233.
32. Collado M.C., Isolauri E., Laitinen K., et al. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr 2010, 92:1023-1030.
33. Salminen S., Gibson G.R., McCartney A.L., et al. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004, 53:1388-1389.
34. Dominguez-Bello M.G., Costello E.K., Contreras M., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010, 107:11971-11975.
35. Neu J., Rushing J. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin Perinatol 2011, 38:321-331.
36. van Nimwegen F., Penders J., Stobberingh E., et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol 2011, 128:948-955. e1-3.
37. WHO 2002. Guidelines for the evaluation of probiotics in food. Available at: Accessed September 29, 2012. http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/.
38. Grześkowiak Ł., Isolauri E., Salminen S., et al. Manufacturing process influences properties of probiotic bacteria. Br J Nutr 2011, 105:887-894.
39. Nivoliez A., Camares O., Paquet-Gachinat M., et al. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35. J Biotechnol 2012, 160:236-241.
40. Tuomola E., Crittenden R., Playne M., et al. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 2001, 73:393S-398S.
41. Isolauri E., Kalliomäki M., Laitinen K., et al. Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Curr Pharm Des 2008, 14:1368-1375.
42. Deshpande G., Rao S., Patole S., et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010, 125:921-930.
43. Kalliomäki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
44. Kalliomäki M., Salminen S., Poussa T., et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361:1869-1871.
45. Kalliomäki M., Salminen S., Poussa T., et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007, 119:1019-1021.
46. Taylor A.L., Dunstan J.A., Prescott S.L. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007, 119:184-191.
47. Kukkonen K., Savilahti E., Haahtela T., et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007, 119:192-198.
48. Abrahamsson T.R., Jakobsson T., Böttcher M.F., et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007, 119:1174-1180.
49. Wickens K., Black P.N., Stanley T.V., et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008, 122:788-794.
50. Kopp M.V., Hennemuth I., Heinzmann A., et al. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008, 121:e850-e856.
51. Soh S.E., Aw M., Gerez I., et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants: effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009, 39:571-578.
52. Niers L., Martín R., Rijkers G., et al. The effects of selected probiotic strains on the development of eczema (the PANDA study). Allergy 2009, 64:1349-1358.
53. West C.E., Hammarström M.L., Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009, 20:430-437.
54. Dotterud C.K., Storrø O., Johnsen R., et al. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010, 163:616-623.
55. Kim J.Y., Kwon J.H., Ahn S.H., et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010, 21:e386-e393.
56. Boyle R.J., Ismail I.H., Kivivuori S., et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011, 66:509-516.
57. Doege K., Grajecki D., Zyriax B.C., et al. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood: a meta-analysis. Br J Nutr 2012, 107:1-6.
58. Rautava S., Kalliomäki M., Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002, 109:119-121.
59. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., et al. Probiotics for treating eczema. Cochrane Database Syst Rev 2008, 4. CD006135.
60. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., et al. Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy 2009, 39:1117-1127.
61. Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997, 99:179-185.
62. Isolauri E., Arvola T., Sütas Y., et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000, 30:1604-1610.
63. Pessi T., Sütas Y., Hurme M., et al. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000, 30:1804-1808.
64. Rosenfeldt V., Benfeldt E., Nielsen S.D., et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003, 111:389-395.
65. Viljanen M., Savilahti E., Haahtela T., et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005, 60:494-500.
66. Sistek D., Kelly R., Wickens K., et al. Is the effect of probiotics on atopic dermatitis confined to food sensitized children?. Clin Exp Allergy 2006, 36:629-633.
67. Gruber C., Wendt M., Sulser C., et al. Randomized, placebo-controlled trial of Lactobacillus GG as treatment of atopic dermatitis in infancy. Allergy 2007, 62:1270-1276.
68. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006, 36:899-906.